Department of Molecular Cancer Science, Yamagata University School of Medicine, Yamagata, Japan.
Cell Death Dis. 2010 Jul 29;1(7):e60. doi: 10.1038/cddis.2010.37.
Recently developed heavy ion irradiation therapy using a carbon beam (CB) against systemic malignancy has numerous advantages. However, the clinical results of CB therapy against glioblastoma still have room for improvement. Therefore, we tried to clarify the molecular mechanism of CB-induced glioma cell death. T98G and U251 human glioblastoma cell lines were irradiated by CB, and caspase-dependent apoptosis was induced in both cell lines in a dose-dependent manner. Knockdown of Bax (BCL-2-associated X protein) and Bak (BCL-2-associated killer) and overexpression of Bcl-2 or Bcl-xl (B-cell lymphoma-extra large) showed the involvement of Bcl-2 family proteins upstream of caspase activation, including caspase-8, in CB-induced glioma cell death. We also detected the activation of extracellular signal-regulated kinase (ERK) and the knockdown of ERK regulator mitogen-activated protein kinase kinase (MEK)1/2 or overexpression of a dominant-negative (DN) ERK inhibited CB-induced glioma cell death upstream of the mitochondria. In addition, application of MEK-specific inhibitors for defined periods showed that the recovery of activation of ERK between 2 and 36 h after irradiation is essential for CB-induced glioma cell death. Furthermore, MEK inhibitors or overexpression of a DN ERK failed to significantly inhibit X-ray-induced T98G and U251 cell death. These results suggested that the MEK-ERK cascade has a crucial role in CB-induced glioma cell death, which is known to have a limited contribution to X-ray-induced glioma cell death.
最近开发的使用碳离子束(CB)治疗全身恶性肿瘤的重离子辐射疗法具有许多优点。然而,CB 治疗脑胶质瘤的临床结果仍有改进的空间。因此,我们试图阐明 CB 诱导的胶质瘤细胞死亡的分子机制。T98G 和 U251 人胶质瘤细胞系用 CB 照射,两种细胞系均呈现出剂量依赖性的半胱天冬酶依赖性细胞凋亡。Bax(BCL-2 相关 X 蛋白)和 Bak(BCL-2 相关杀伤蛋白)的敲低以及 Bcl-2 或 Bcl-xl(B 细胞淋巴瘤-额外大)的过表达表明,半胱天冬酶激活的上游涉及 Bcl-2 家族蛋白,包括 caspase-8,在 CB 诱导的胶质瘤细胞死亡中。我们还检测到细胞外信号调节激酶(ERK)的激活,以及 ERK 调节丝裂原活化蛋白激酶激酶(MEK)1/2 的敲低或显性负(DN)ERK 的过表达抑制了线粒体上游的 CB 诱导的胶质瘤细胞死亡。此外,在特定时间段内应用 MEK 特异性抑制剂表明,照射后 2 至 36 小时内 ERK 激活的恢复对于 CB 诱导的胶质瘤细胞死亡是必需的。此外,MEK 抑制剂或过表达显性负 ERK 并不能显著抑制 X 射线诱导的 T98G 和 U251 细胞死亡。这些结果表明,MEK-ERK 级联在 CB 诱导的胶质瘤细胞死亡中起着至关重要的作用,而众所周知,其对 X 射线诱导的胶质瘤细胞死亡的贡献有限。